A new system for the continuous direct recording of blood pressure and heart rate in the conscious rat

Pharmacologic profiles of KRH-594, a novel nonpeptide angiotensin II-receptor antagonist

We studied pharmacologic profiles of KRH-594, dipotassium (Z)-2-[[5-ethyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl-1,3,4 -thiadiazolin-2-ylidene]aminocarbonyl]-1-cyclopentenecarb oxylate, a novel angiotensin II (AII)-receptor antagonist. KRH-594 potently displaced specific binding of [125I]-AII from AT1 receptor with a Ki of 0.39 nM in rat liver membranes, but not from AT2 receptor in bovine cerebellar membranes (Ki > 10 microM). KRH-594 exhibited no affinity for 21 other receptors and two enzymes [50% inhibitory concentration (IC50) > 10 microM], demonstrating its high specificity toward AT1 receptors. In isolated rabbit aorta, KRH-594 caused nonparallel shifts to the right of the dose-response curve to AII and decreased the maximal response with a pK(B) of 10.4. We evaluated the in vivo efficacy and the duration of action in freely moving rats under nonfasting conditions. In normotensive rats, orally administered KRH-594 inhibited AII-induced pressor responses with a 50% inhibitory dose (ID50) of 0.39 mg/kg. In spontaneously hypertensive rats (SHRs), both KRH-594 (1 mg/kg p.o.) and losartan (10 mg/kg p.o.) exerted similar blood pressure-reducing effects, and their effects were still significant at 24 h after drug administration. We concluded that KRH-594 is a specific and efficacious AT1 antagonist that may find its use in the treatment of human hypertension.

A fully automated system using a microcomputer for the hypertensive activity assays of drugs in the anesthetized rat

A complete system is described for the computerized automation of the determination of activity of hypertensive drugs in the anesthetized rat. The microcomputer used was the Apple IIe, and the automation was performed by a purpose-designed command module. The series of injections of hypertensive drugs was controlled by the microcomputer through the intermediary of the command module. All processing of the signal (hypertension peak), calculation of the data obtained, statistical processing, and archive storage of the results was carried out entirely by the microcomputer. The computer was able unaided to control three work stations simultaneously without requiring synchronization.

An integrated mini-computer system for the automatic control of pharmacological experiments and calculation of results

A mini-computer system for the automation of pharmacological experiments and for the calculation, printing and storing of results is described. A link between the 1) control unit which powers the pumps, valves, etc., and 2) the computer which processes the digital data allows the synchronization of data collection with the time course of the experiment. Thus results may be immediately expressed in absolute (i.e. stimulus-induced change in tension, etc.) or relative (i.e. % change in response due to drug administration) terms.